Human breast cancer cells activate procollagenase-1 and invade type I collagen: Invasion is inhibited by all-trans retinoic acid

Clinical and Experimental Metastasis

Volumn 17, Issue 3, 1999, Pages 231-238

  Benbow, Ulrike ^a   Schoenermark, Matthias P ^a,b   Orndorff, Kenneth A ^a   Givan, Alice L ^a   Brinckerhoff, Constance E ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Confocal laser scanning microscopy; Invasion assay; Matrix metalloproteinases; MDA MB 231 cells; Retinoids

Indexed keywords

COLLAGEN TYPE 1; COLLAGENASE; FN 439; GELATINASE B; MATRIX METALLOPROTEINASE INHIBITOR; RETINOIC ACID; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER INHIBITION; CANCER INVASION; CANCER MODEL; CONFOCAL LASER MICROSCOPY; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; METASTASIS; PROTEIN EXPRESSION; SCANNING ELECTRON MICROSCOPY; TUMOR CELL LINE;

BLOTTING, NORTHERN; BREAST NEOPLASMS; COLLAGEN; COLLAGENASES; CULTURE MEDIA, CONDITIONED; ENZYME INHIBITORS; EXTRACELLULAR SPACE; FIBROBLASTS; GELATINASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYDROXAMIC ACIDS; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; METALLOENDOPEPTIDASES; MICROSCOPY, ELECTRON, SCANNING; NEOPLASM INVASIVENESS; OLIGOPEPTIDES; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0032770243     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006639214618     Document Type: Article

References (37)

1. Flug M, Kopf-Maier P. The basement membrane, its involvement in carcinoma cell invasion. Acta Anat 1995; 152: 69-84.
2. Liotta LA, Rao CN, Wewer UM. Biochemical interactions of tumor cellswith the basement membrane. Ann Rev Biochem 1989; 55: 1037-57.
3. Chambers AF, Matrisian LM. Changing views of the role of matrixmetalloproteinases in metastasis. J Nat Cancer Inst 1997; 89: 1260-70.
4. Liotta LA. Cancer cell invasion and metastasis. Scientific American 1992; 266: 54-9, 62-3.
5. Poste G, Fidler IJ. The pathogenesis of cancer metastasis. Nature 1990; 283: 139-46.
6. Mullins DE, Rohrlich ST. The role of proteinases in cellular invasiveness. Biochim Biophys Acta 1983; 695: 177-14.
7. Birkedal-Hansen H. Proteolytic remodeling of extracellular matrix. Curr OpinCell Biol 1995; 7: 728-35.
8. Matrisian LM. The matrix-degrading metalloproteinases. Bioessays 1992; 14: 455-63.
9. Nagase H. In: Zinc Metalloproteinses in Health, Disease, pp, 153-04, Tayler & Francis, 1996.
10. Basset P, Okada A, Chenard MP, et al. Matrix metalloproteinases as stromal effectors of human carcinoma progression: Therapeutic implications. Matrix Biol. 1997; 15: 535-41.
11. Nagase H. Activation mechanism of matrix metalloproteinases. Biol Chem. 1997; 378: 151-60.
12. Heppner KJ, Matrisian LM, Jensen RA, Rodgers WH. Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am J Pathol 1996; 149: 2738-42.
13. Chen JH, Vercamer C, Li Z, Paulin D, Vandenbunder B, Stehelin D. PEA3 transactivates vimentin promoter in mammary epithelial, tumor cells. Oncogene 1996; 13: 1667-75.
14. Benbow U, Rutter JL, Lowrey CH, Brinckerhoff CE. Transcriptional repression of the human collagenase-1 (MMP-1) gene in MDA231 breast cancer cells by all-trans retinoic acid requires distal regions of the promoter. Br J Cancer 1999; 79: 221-8.
15. Schroen DJ, Brinckerhoff CE. Nuclear hormone receptors inhibit matrix metalloproteinase (MMP) gene expression through diverse mechanisms. Gene Expression 1996; 6: 197-207.
16. Moon RC, Mehta RG, Detrisac CJ. Retinoids as chemopreventive agents for breast cancer. Cancer Detect Prev 1992: 6: 73-9.
17. Anzano MA, Byers SW, Smith JM, et al. Prevention of breast cancer in the rat with 9-cis-retinoic acid as a single agent, in combination with tamoxifen. Cancer Res 1994; 54: 4614-7.
18. Lotan R. Effects of Vitamin A, its analogs (retinoids) on normal, neoplastic cells. Biochem Biophys Acta 1980; 605: 33-9.
19. Lippman SM, Heyman RA, Kurie JM, Benner SE, Hong WK. Retinoids, chemoprevention: Clinical, basic studies. J Cell Biochem Suppl 1995; 22: 1-10.
20. Sankaranarayanan R, Mathew B. Retinoids as cancer-preventive agents. IARC Sci Publ 1996; 139: 47-59.
21. Rutter JL, Benbow U, Coon CI, Brinckerhoff CE. Cell-type specific regulation of human interstitial collagenase-I gene expression in human fibroblasts, BC-8701 breast cancer cells. J Cell Biochem 1997; 66: 1-15.
22. Schonermark MP, Bock O, Buchner A, Steinmeier R, Benbow U, Lenarz T. Quantification of tumor cell invasion using confocal laser scan microscopy. Nature Med 1997; 3: 1167-71.
23. Bae SN, Arand G, Azzam H, et al. Molecular, cellular analysis of basement membrane invasion by human breast cancer cells in Matrigel-based in vitro assays. Breast Cancer Res Treat 1993; 24: 241-55.
24. Liotta LA, Rao CN, Wewer UM. Biochemical interactions of tumor cells with the basement membrane. Ann Rev Biochem 1986; 55: 1037-57.
25. Liotta LA. Cancer cell invasion and metastasis. Scientific American 1992; 266: 54-9, 62-3.
26. Seewaldt VL, Johnson BS, Parker MB, Collins SJ, Swisshelm K. Expression of retinoic acid receptor beta mediates retinoic acid-induced growth arrest, apoptosis in breast cancer cells. Cell Growth Differ 1995; 6: 1077-88.
27. Jacob K, Bosserhoff AK, Wach F, et al. Characterization of selected strongly, weakly invasive sublines of a primary human melanoma cell line, isolation of subtractive cDNA clones. Intern J Cancer 1995; 60: 668-75.
28. Odake S, Morita Y, Morikawa T, Yoshida N, Hori H, Nagai Y. Inhibitor of matrix metalloproteinases by peptidyl hydroxamic acid. Biochem Biophy Res Comm 1994; 199: 1442-6.
29. Suzuki K, Enghild JJ, Morodomy T, Salvesen G, Nagase H. Mechanisms of activation of tissue procollagenase by matrix metaollproteinase 3 (stromelysin). Biochemistry 1990; 29: 10251-7.
30. Farina RF, Coppa A, Tiberio A, et al. Transforming growth factor-β1 enhances the invasiveness of human MDA-MB-231 breast cancer cells by up-regulating urokinase activity. Int J Cancer 1998; 75: 721-30.
31. Okada A, Bellocq JP, Rouyer N, et al. Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, head, neck carcinomas. Proc Natl Acad Sci USA; 92: 2730-4.
32. Yu M, Sato H, Seiki M, Thompson EW. Complex regulation of membrane-type matrix metalloproteinase expression, matrix metalloproteinase-2 activation by concanavalin A in MDA-MB-231 human breast cancer cells. Cancer Res 1995; 55: 3272-7.
33. MacDougall JR, Matrisian LM. Contributions of tumor, stromal matrix metalloproteinases to tumor progression, invasion, metastasis. Cancer Metastasis Rev 1995; 14: 351-62.
34. Tiberio A, Farina AR, Tacconelli A, Cappabianca L, Mackay RA. Retinoic acid-enhanced invasion through reconstituted basement membrane by human SK-N-SH neuroblastoma cells involves membrane-associated tissue-type plasminogen activator. Intern J Cancer 1997; 73: 740-8.
35. Gilles C, Polette M, Birembaut P, Brunner N, Thompson EW. Expression of c-ets-1 mRNA is associated with an invasive: EMT-derived phenotype in breast carcinoma cell lines. Clin Exp Met 1997; 15: 519-26.
36. Ohuchi E, Ima K, Fujii Y, Sato H. Membrane type I matrix metalloproteinase digest interstitial collagenase, other extracellular matrix macromolecules. J Biol Chem 1997; 272: 2446-51.
37. Costa A. Breast cancer chemoprevention, Eur J Cancer 1993; 29A: 589-92.